Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae.
Anti-Bacterial Agents
/ pharmacology
Azabicyclo Compounds
/ pharmacology
Bacteremia
/ microbiology
Carbapenem-Resistant Enterobacteriaceae
/ drug effects
Ceftazidime
/ pharmacology
Drug Combinations
Enterobacteriaceae Infections
/ microbiology
Humans
Imipenem
/ pharmacology
Klebsiella pneumoniae
/ drug effects
Microbial Sensitivity Tests
beta-Lactamases
/ genetics
carbapenem-resistant Enterobacteriaceae
ceftazidime-avibactam
imipenem-relebactam
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
28
03
2019
accepted:
20
06
2019
pubmed:
3
7
2019
medline:
18
7
2020
entrez:
3
7
2019
Statut:
epublish
Résumé
Carbapenem-resistant
Identifiants
pubmed: 31262761
pii: AAC.00672-19
doi: 10.1128/AAC.00672-19
pmc: PMC6709495
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Azabicyclo Compounds
0
Drug Combinations
0
avibactam, ceftazidime drug combination
0
Imipenem
71OTZ9ZE0A
Ceftazidime
9M416Z9QNR
beta-Lactamases
EC 3.5.2.6
oxacillinase
EC 3.5.2.6
relebactam
Y1MYA2UHFL
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI090155
Pays : United States
Informations de copyright
Copyright © 2019 American Society for Microbiology.
Références
Antimicrob Agents Chemother. 2014;58(4):1835-46
pubmed: 24379206
J Clin Microbiol. 2013 Dec;51(12):4073-8
pubmed: 24088853
Drugs. 2018 Jan;78(1):65-98
pubmed: 29230684
Clin Infect Dis. 2014 May;58(9):1274-83
pubmed: 24463280
Clin Infect Dis. 2018 Apr 3;66(8):1290-1297
pubmed: 29165604
Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):587-604
pubmed: 28990132
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167547